Microba Life Revenue vs. Net Income
| MAP Stock | 0.19 0.01 5.56% |
Total Revenue | First Reported 2010-12-31 | Previous Quarter 12.1 M | Current Value 12.7 M | Quarterly Volatility 3.7 M |
For Microba Life profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Microba Life to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Microba Life Sciences utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Microba Life's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Microba Life Sciences over time as well as its relative position and ranking within its peers.
Microba |
Microba Life Sciences Net Income vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Microba Life's current stock value. Our valuation model uses many indicators to compare Microba Life value to that of its competitors to determine the firm's financial worth. Microba Life Sciences is rated top company in revenue category among its peers. It is regarded third in net income category among its peers . At this time, Microba Life's Total Revenue is comparatively stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Microba Life's earnings, one of the primary drivers of an investment's value.Microba Revenue vs. Competition
Microba Life Sciences is rated top company in revenue category among its peers. Market size based on revenue of Health Care industry is now estimated at about 4.45 Billion. Microba Life adds roughly 12.09 Million in revenue claiming only tiny portion of equities under Health Care industry.
Microba Net Income vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Microba Life |
| = | 12.09 M |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Microba Life |
| = | (19.94 M) |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Microba Net Income Comparison
Microba Life is currently under evaluation in net income category among its peers.
Microba Life Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Microba Life, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Microba Life will eventually generate negative long term returns. The profitability progress is the general direction of Microba Life's change in net profit over the period of time. It can combine multiple indicators of Microba Life, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 2.2 M | 1.5 M | |
| Operating Income | -26.8 M | -25.5 M | |
| Income Before Tax | -20 M | -19 M | |
| Total Other Income Expense Net | 6.9 M | 7.2 M | |
| Net Loss | -11.4 M | -12 M | |
| Net Loss | -19.9 M | -18.9 M | |
| Income Tax Expense | -51.3 K | -53.9 K | |
| Net Interest Income | 940.3 K | 987.3 K | |
| Interest Income | 1 M | 510.2 K | |
| Net Loss | -11.4 M | -12 M | |
| Change To Netincome | 237.6 K | 169.8 K |
Microba Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Microba Life. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Microba Life position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Microba Life's important profitability drivers and their relationship over time.
Use Microba Life in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Microba Life position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Microba Life will appreciate offsetting losses from the drop in the long position's value.Microba Life Pair Trading
Microba Life Sciences Pair Trading Analysis
The ability to find closely correlated positions to Microba Life could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Microba Life when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Microba Life - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Microba Life Sciences to buy it.
The correlation of Microba Life is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Microba Life moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Microba Life Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Microba Life can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Microba Life position
In addition to having Microba Life in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Healthcare Thematic Idea Now
Healthcare
Companies that provide healthcare goods and services including hospitals, health maintenance organizations, HMOs, or medical aid manufacturers. The Healthcare theme has 20 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Healthcare Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Microba Stock Analysis
When running Microba Life's price analysis, check to measure Microba Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Microba Life is operating at the current time. Most of Microba Life's value examination focuses on studying past and present price action to predict the probability of Microba Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Microba Life's price. Additionally, you may evaluate how the addition of Microba Life to your portfolios can decrease your overall portfolio volatility.